Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
It’s not often that a company with the scale and…
Sell
50
NECB Quote, Financials, Valuation and Earnings
Last price:
$25.10
Seasonality move
:
-2.41%
Day range:
$24.29 - $25.55
52-week range:
$14.26 - $31.72
Dividend yield:
1.62%
P/E ratio:
7.02x
P/S ratio:
3.14x
P/B ratio:
1.04x
Volume:
131.1K
Avg. volume:
67.9K
1-year change:
43.28%
Market cap:
$321M
Revenue:
$101M
EPS (TTM):
$3.60
| Period Ending | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $42.7M | $41.6M | $45.7M | $65.5M | $101M | |
| Revenue Growth (YoY) | 3.94% | -2.57% | 9.8% | 43.4% | 54.22% | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $15.4M | $16.6M | $17.9M | $17.2M | $20.9M | |
| Other Inc / (Exp) | $291K | $288K | -$389K | -$1.6M | $156K | |
| Operating Expenses | $15.4M | $16.4M | $17.9M | $16.9M | $20.8M | |
| Operating Income | -- | -- | -- | -- | -- | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | $16.9M | $15.6M | $15.6M | $34.4M | $64.7M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $4M | $3.3M | $3.7M | $9.6M | $18.5M | |
| Net Income to Company | $13M | $12.3M | $11.9M | $24.8M | $46.3M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $13M | $12.3M | $11.9M | $24.8M | $46.3M | |
| Basic EPS (Cont. Ops) | $1.08 | $0.76 | $0.75 | $1.61 | $3.32 | |
| Diluted EPS (Cont. Ops) | $1.08 | $0.76 | $0.75 | $1.58 | $3.32 | |
| Weighted Average Basic Share | $12M | $16.2M | $15.9M | $15.4M | $13.9M | |
| Weighted Average Diluted Share | $12M | $16.2M | $15.9M | $15.7M | $13.9M | |
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | $32M | $25.6M | $20.7M | $42.6M | $100M | |
| Revenue (Reported) | $42.7M | $41.6M | $45.7M | $65.5M | $101M | |
| Operating Income (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Adjusted) | $32M | $25.6M | $20.7M | $42.6M | $100M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $10.3M | $11.4M | $17.7M | $24.6M | $26.8M | |
| Revenue Growth (YoY) | 96.5% | 10.72% | 54.84% | 38.87% | 8.98% | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $3.9M | $4.8M | $4.4M | $5.2M | $5.7M | |
| Other Inc / (Exp) | -- | -$154K | -$573K | -$430K | $547K | |
| Operating Expenses | $3.8M | $4.8M | $4.4M | $5.2M | $5.7M | |
| Operating Income | -- | -- | -- | -- | -- | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | $4.1M | $995K | $9.9M | $16.3M | $17.6M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $956K | $265K | $2.4M | $4.4M | $4.9M | |
| Net Income to Company | $3.1M | $730K | $7.5M | $11.8M | $12.7M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $3.1M | $730K | $7.5M | $11.8M | $12.7M | |
| Basic EPS (Cont. Ops) | $0.19 | $0.05 | $0.49 | $0.80 | $0.97 | |
| Diluted EPS (Cont. Ops) | $0.19 | $0.05 | $0.49 | $0.80 | $0.95 | |
| Weighted Average Basic Share | $12.2M | $15.6M | $15.5M | $14.7M | $13.1M | |
| Weighted Average Diluted Share | $12.2M | $15.6M | $15.5M | $14.8M | $13.4M | |
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | $6.3M | $2.2M | $11.9M | $26.3M | $32.5M | |
| Revenue (Reported) | $10.3M | $11.4M | $17.7M | $24.6M | $26.8M | |
| Operating Income (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Adjusted) | $6.3M | $2.2M | $11.9M | $26.3M | $32.5M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $36M | $44.2M | $56M | $94.8M | $106.9M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $13.9M | $17.7M | $17.1M | $20.4M | $22.6M | |
| Other Inc / (Exp) | $299K | -$227K | -$1.8M | -$265K | $1.1M | |
| Operating Expenses | $13.9M | $17.6M | $17.2M | $19.9M | $22.6M | |
| Operating Income | -- | -- | -- | -- | -- | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | $12.9M | $14.1M | $27.3M | $60.2M | $68.4M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $3.2M | $3M | $6.5M | $17.8M | $19.5M | |
| Net Income to Company | $9.7M | $11.2M | $20.8M | $42.4M | $49M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $9.7M | $11.2M | $20.8M | $42.4M | $49M | |
| Basic EPS (Cont. Ops) | $0.75 | $0.76 | $1.34 | $2.86 | $3.64 | |
| Diluted EPS (Cont. Ops) | $0.74 | $0.76 | $1.34 | $2.86 | $3.60 | |
| Weighted Average Basic Share | -- | -- | -- | -- | -- | |
| Weighted Average Diluted Share | -- | -- | -- | -- | -- | |
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | $22.3M | $19.8M | $33M | $87.2M | $122.4M | |
| Revenue (Reported) | $36M | $44.2M | $56M | $94.8M | $106.9M | |
| Operating Income (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Adjusted) | $22.3M | $19.8M | $33M | $87.2M | $122.4M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $30.7M | $33.4M | $43.7M | $73.1M | $78.6M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $10.8M | $13.3M | $12.5M | $15.6M | $17.3M | |
| Other Inc / (Exp) | $299K | -$216K | -$1.6M | -$328K | $445K | |
| Operating Expenses | $10.8M | $13.3M | $12.6M | $15.6M | $17.3M | |
| Operating Income | -- | -- | -- | -- | -- | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | $11.6M | $10.1M | $21.8M | $47.6M | $51.3M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $2.7M | $2.4M | $5.2M | $13.4M | $14.4M | |
| Net Income to Company | $8.9M | $7.7M | $16.6M | $34.2M | $36.9M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $8.9M | $7.7M | $16.6M | $34.2M | $36.9M | |
| Basic EPS (Cont. Ops) | $0.67 | $0.48 | $1.07 | $2.32 | $2.82 | |
| Diluted EPS (Cont. Ops) | $0.67 | $0.48 | $1.07 | $2.32 | $2.78 | |
| Weighted Average Basic Share | $36.3M | $47.9M | $46.6M | $44.1M | $39.3M | |
| Weighted Average Diluted Share | $36.3M | $47.9M | $46.6M | $44.2M | $39.8M | |
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | $19.8M | $14M | $26.3M | $71M | $93.3M | |
| Revenue (Reported) | $30.7M | $33.4M | $43.7M | $73.1M | $78.6M | |
| Operating Income (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Adjusted) | $19.8M | $14M | $26.3M | $71M | $93.3M | |
| Period Ending | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $127.8M | $69.3M | $152.4M | $95.4M | $68.8M | |
| Short Term Investments | $5K | $2K | $1K | $1K | -- | |
| Accounts Receivable, Net | $4M | $3.8M | $4.3M | $8.6M | $12.3M | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | -- | -- | -- | -- | -- | |
| Total Current Assets | $131.7M | $73.1M | $156.7M | $104M | $81.1M | |
| Property Plant And Equipment | $20.1M | $22.1M | $26.8M | $28.7M | $30.4M | |
| Long-Term Investments | $19.2M | $17.7M | $37.8M | $44.4M | $34M | |
| Goodwill | $749K | $651K | $651K | $200K | -- | |
| Other Intangibles | -- | -- | -- | -- | -- | |
| Other Long-Term Assets | -- | -- | -- | -- | -- | |
| Total Assets | $955.2M | $968.2M | $1.2B | $1.4B | $1.8B | |
| Accounts Payable | -- | -- | -- | -- | -- | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $8.5M | $8.9M | $13.5M | $14.8M | $13.6M | |
| Long-Term Debt | $21M | $28M | $28M | $21M | $64M | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $813.1M | $814.4M | $973.7M | $1.2B | $1.5B | |
| Common Stock | $132K | $132K | $164K | $161K | $142K | |
| Other Common Equity Adj | -- | -- | -- | -- | -- | |
| Common Equity | $142.1M | $153.8M | $251.4M | $262M | $279.3M | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $142.1M | $153.8M | $251.4M | $262M | $279.3M | |
| Total Liabilities and Equity | $955.2M | $968.2M | $1.2B | $1.4B | $1.8B | |
| Cash and Short Terms | $127.8M | $69.3M | $152.4M | $95.4M | $68.8M | |
| Total Debt | $21M | $28M | $28M | $21M | $64M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | -- | $108.1M | $55M | $106.8M | $97.9M | |
| Short Term Investments | -- | $2K | $1K | -- | -- | |
| Accounts Receivable, Net | -- | $4M | $6.6M | $11.3M | $13.5M | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | -- | -- | -- | -- | -- | |
| Total Current Assets | -- | $112.1M | $61.7M | $118.1M | $111.4M | |
| Property Plant And Equipment | -- | $26.6M | $28.9M | $27.8M | $29.4M | |
| Long-Term Investments | -- | $28.5M | $45M | $33.2M | $35.6M | |
| Goodwill | -- | $651K | $651K | $200K | -- | |
| Other Intangibles | -- | -- | -- | -- | -- | |
| Other Long-Term Assets | -- | -- | -- | -- | -- | |
| Total Assets | -- | $1.1B | $1.3B | $1.7B | $2B | |
| Accounts Payable | -- | -- | -- | -- | -- | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | -- | $9.1M | $11.2M | $12.8M | $16M | |
| Long-Term Debt | -- | $28M | $21M | $64M | $7M | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | -- | $859.3M | $1B | $1.4B | $1.7B | |
| Common Stock | -- | $164K | $162K | $145K | $140K | |
| Other Common Equity Adj | -- | -- | -- | -- | -- | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | -- | $248.7M | $260M | $272.4M | $309.6M | |
| Total Liabilities and Equity | -- | $1.1B | $1.3B | $1.7B | $2B | |
| Cash and Short Terms | -- | $108.1M | $55M | $106.8M | $97.9M | |
| Total Debt | -- | $28M | $21M | $64M | $7M | |
| Period Ending | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $13M | $12.3M | $11.9M | $24.8M | $46.3M | |
| Depreciation & Amoritzation | $916K | $1.1M | $1.1M | $1.2M | $1.2M | |
| Stock-Based Compensation | $299K | $257K | $931K | $1.3M | $3.1M | |
| Change in Accounts Receivable | $171K | $116K | -$445K | -$4.3M | -$3.7M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $13.5M | $15.7M | $21.6M | $27.5M | $42.8M | |
| Capital Expenditures | $4M | $1.3M | $6.5M | $3.3M | $626K | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$6.6M | -$72.1M | -$178.9M | -$256.6M | -$357.8M | |
| Dividends Paid (Ex Special Dividend) | -$788K | -$1M | -$2.3M | -$6.9M | -$3.7M | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | $7M | -- | -- | $50M | |
| Long-Term Debt Repaid | -$21.5M | -- | -$7.8M | -$7M | -$7M | |
| Repurchase of Common Stock | -- | -- | -- | -$9.3M | -$28.7M | |
| Other Financing Activities | -$385K | -$570K | -$374K | $485K | -$349K | |
| Cash From Financing | $69.4M | -$2M | $240.4M | $172.1M | $288.4M | |
| Beginning Cash (CF) | $51.4M | $127.7M | $69.2M | $152.3M | $95.3M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $76.3M | -$58.5M | $83.1M | -$57M | -$26.6M | |
| Ending Cash (CF) | $127.7M | $69.2M | $152.3M | $95.3M | $68.7M | |
| Levered Free Cash Flow | $9.4M | $14.4M | $15.1M | $24.2M | $42.2M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $3.1M | $730K | $7.5M | $11.8M | $12.7M | |
| Depreciation & Amoritzation | $250K | $269K | $293K | $286K | $286K | |
| Stock-Based Compensation | $59K | $492K | $271K | $773K | $955K | |
| Change in Accounts Receivable | $378K | -$415K | -$1.4M | -$792K | $10K | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $7.1M | $5.5M | $7.2M | $12.9M | $14.4M | |
| Capital Expenditures | $226K | $626K | $375K | $163K | $176K | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$3.8M | -$91.1M | -$93.9M | -$116.4M | -$53.9M | |
| Dividends Paid (Ex Special Dividend) | -$147K | -$983K | -$983K | -$902K | -$1.4M | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | $50M | -- | |
| Long-Term Debt Repaid | -- | -$7.8M | -- | -- | -$40M | |
| Repurchase of Common Stock | -- | -- | -$3.2M | -$8.9M | -- | |
| Other Financing Activities | -$28K | $20.6M | $560K | $358K | $559K | |
| Cash From Financing | -$2.3M | $29.8M | $55.4M | $90.3M | $23.4M | |
| Beginning Cash (CF) | $72.4M | $163.8M | $86.2M | $119.9M | $113.9M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $1.1M | -$55.8M | -$31.3M | -$13.2M | -$16.1M | |
| Ending Cash (CF) | $73.5M | $108M | $54.9M | $106.7M | $97.8M | |
| Levered Free Cash Flow | $6.9M | $4.8M | $6.8M | $12.8M | $14.2M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $9.7M | $11.2M | $20.8M | $42.4M | $49M | |
| Depreciation & Amoritzation | $934K | $1.2M | $1.2M | $1.3M | $1.2M | |
| Stock-Based Compensation | $229K | $771K | $1M | $2.8M | $3.3M | |
| Change in Accounts Receivable | -$15K | -$247K | -$2.6M | -$4.7M | -$2.1M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $14.8M | $13.7M | $23.4M | $44M | $50.4M | |
| Capital Expenditures | $1.2M | $6.1M | $4M | $448K | $623K | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$104.4M | -$118.5M | -$230.3M | -$380.1M | -$252.4M | |
| Dividends Paid (Ex Special Dividend) | -$1M | -$1.4M | -$6.9M | -$3.8M | -$4.5M | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $31.6M | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -$7.8M | -$7M | -$7M | -$57M | |
| Repurchase of Common Stock | -- | -- | -$3.2M | -$29.5M | -$7.8M | |
| Other Financing Activities | -$785K | $95.3M | -$95.3M | $214K | -$49K | |
| Cash From Financing | $25.6M | $139.3M | $153.8M | $388M | $193.1M | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$63.9M | $34.5M | -$53.1M | $51.8M | -$8.9M | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | $13.6M | $7.6M | $19.4M | $43.5M | $49.8M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $8.9M | $7.7M | $16.6M | $34.2M | $36.9M | |
| Depreciation & Amoritzation | $736K | $837K | $892K | $920K | $884K | |
| Stock-Based Compensation | $180K | $694K | $775K | $2.3M | $2.6M | |
| Change in Accounts Receivable | $167K | -$196K | -$2.4M | -$2.7M | -$1.2M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $14.7M | $12.7M | $14.4M | $30.9M | $38.5M | |
| Capital Expenditures | $877K | $5.7M | $3.2M | $380K | $377K | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$58.8M | -$105.2M | -$156.6M | -$280.1M | -$174.7M | |
| Dividends Paid (Ex Special Dividend) | -$879K | -$1.3M | -$5.9M | -$2.8M | -$3.7M | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | $7M | -- | -- | $50M | -- | |
| Long-Term Debt Repaid | -- | -$7.8M | -$7M | -$7M | -$57M | |
| Repurchase of Common Stock | -- | -- | -$3.2M | -$23.4M | -$2.5M | |
| Other Financing Activities | -$567K | $95.3M | $413K | $142K | $442K | |
| Cash From Financing | -$10M | $131.3M | $44.8M | $260.6M | $165.4M | |
| Beginning Cash (CF) | $243.2M | $288.9M | $413.2M | $292.2M | $290M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$54.2M | $38.8M | -$97.3M | $11.4M | $29.1M | |
| Ending Cash (CF) | $189.1M | $327.7M | $315.8M | $303.6M | $319.1M | |
| Levered Free Cash Flow | $13.8M | $7M | $11.2M | $30.5M | $38.1M | |
Get NECB Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
NECB
Sector
P/E ratio
7.02x
11.99x
PEG ratio
0.27x
0.36x
P/B ratio
1.04x
1.05x
Price / LTM sales
3.14x
2.55x
Growth Metrics
NECB
Sector
Revenue growth
8.98%
6.08%
Earnings growth
18.75%
6.45%
Revenue (5-year growth)
19.72%
5.85%
Earnings forecast
$0.91
$0.56
Profitability
NECB
Sector
Profitability FY 2024
--
$179.9M
Return on invested capital
14.58%
5.27%
Return on assets
2.65%
0.98%
Return on equity
16.88%
9.43%
Earnings Date
Last Earnings Date
Oct
28
Next Earnings Date
Jan
31
Estimated Next Earnings Date
Jan
27
Balance Sheet
NECB
Sector
Total cash
$97.9M
$615.3M
Short term investments
--
$408.4M
Total assets
$1.8B
$4.5B
Long term debt
$7M
$270.8M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will Tyson Foods Stock Bounce Back?
Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…
Will Iovance Biotherapeutics Stock Bounce Back?
Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…
Stock Ideas
Buy
64
Is AAPL Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 42x
Buy
52
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 113x
Buy
55
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 37x
Alerts
Buy
61
QMCO alert for Dec 21
Quantum [QMCO] is up 26.28% over the past day.
Sell
46
NUKK alert for Dec 21
Nukkleus [NUKK] is down 22.94% over the past day.
Sell
1
IIPR alert for Dec 21
Innovative Industrial Properties [IIPR] is down 22.7% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
